Stay updated on Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry 'v3.3.4' was added to the Study Record Versions, and the previous revision 'v3.3.3' was removed from the version list. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T04:56:31.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.2%
    Check dated 2025-12-24T14:54:41.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page history shows a new Revision: v3.3.2 replacing v3.2.0, indicating a minor site maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:56.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    - The government funding/operating status banner at the top of the page was removed. This affects only site-wide messaging and does not change the study record details.
    Difference
    0.8%
    Check dated 2025-11-18T07:28:13.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Version history now includes entries for Study Status (2019-03-08), Recruitment Status (2019-08-05 and 2022-11-21), and IPDSharing (2020-06-17). These updates reflect changes to how the trial is described and accessed.
    Difference
    0.1%
    Check dated 2025-10-27T21:05:43.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    13%
    Check dated 2025-10-06T08:12:12.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.